- Home
- AXGN vs QURE Comparison
AXGN vs QURE Comparison
Compare AXGN & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- QURE
- Stock Information
- Founded
- AXGN N/A
- QURE 1998
- Country
- AXGN United States
- QURE Netherlands
- Employees
- AXGN N/A
- QURE N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- AXGN Health Care
- QURE Health Care
- Exchange
- AXGN Nasdaq
- QURE Nasdaq
- Market Cap
- AXGN 813.6M
- QURE 860.8M
- IPO Year
- AXGN N/A
- QURE 2007
- Fundamental
- Price
- AXGN $18.09
- QURE $14.05
- Analyst Decision
- AXGN Strong Buy
- QURE Strong Buy
- Analyst Count
- AXGN 4
- QURE 8
- Target Price
- AXGN $15.00
- QURE $32.43
- AVG Volume (30 Days)
- AXGN 614.5K
- QURE 1.3M
- Earning Date
- AXGN 03-04-2025
- QURE 02-26-2025
- Dividend Yield
- AXGN N/A
- QURE N/A
- EPS Growth
- AXGN N/A
- QURE N/A
- EPS
- AXGN N/A
- QURE N/A
- Revenue
- AXGN $180,855,000.00
- QURE $28,587,000.00
- Revenue This Year
- AXGN $18.91
- QURE $153.92
- Revenue Next Year
- AXGN $13.02
- QURE N/A
- P/E Ratio
- AXGN N/A
- QURE N/A
- Revenue Growth
- AXGN 18.79
- QURE N/A
- 52 Week Low
- AXGN $5.55
- QURE $3.73
- 52 Week High
- AXGN $18.96
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- AXGN 63.51
- QURE 48.03
- Support Level
- AXGN $14.00
- QURE $13.04
- Resistance Level
- AXGN $18.96
- QURE $14.32
- Average True Range (ATR)
- AXGN 1.22
- QURE 1.09
- MACD
- AXGN 0.19
- QURE -0.75
- Stochastic Oscillator
- AXGN 82.46
- QURE 16.40
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.